LDLR and atherosclerosis: Mechanistically, FEN treatment results in retinoic acid signalling mediated induction of sphingomyelinase gene Smpd3 and an increase in circulating ceramides and thereby may contribute to the increased development of atherosclerosis in LDLR−/− mice (as illustrated in Supplemental Fig. 7).